Laurus Labs Strengthens Biotechnology Arm with ₹40 Crore Investment

Laurus Labs has announced a ₹40 crore investment in its subsidiary, Laurus Bio, to enhance its production of recombinant proteins and other biotechnological solutions. This funding supports innovative projects aimed at serving global industries like pharmaceuticals and nutraceuticals. Laurus Bio, known for its expertise in sustainable biotechnology, will leverage this investment to expand its capabilities while adhering to eco-friendly practices. The move underlines Laurus Labs’ commitment to growth and innovation in biotechnology.